Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| T47D | Ulixertinib | 0.001 | 1.1403 | -0.00466 |
| T47D | Ulixertinib | 0.001 | 0.9498 | 0.00623 |
| T47D | Ulixertinib | 0.003162278 | 1.0700 | -0.00462 |
| T47D | Ulixertinib | 0.003162278 | 1.0188 | 0.00216 |
| T47D | Ulixertinib | 0.003162278 | 0.9265 | 0.00456 |
| T47D | Ulixertinib | 0.01 | 0.9260 | 0.00560 |
| T47D | Ulixertinib | 0.01 | 0.9912 | -0.00483 |
| T47D | Ulixertinib | 0.01 | 1.1013 | -0.00937 |
| T47D | Ulixertinib | 0.031622777 | 0.7299 | 0.03217 |
| T47D | Ulixertinib | 0.031622777 | 1.0042 | -0.00697 |
| T47D | Ulixertinib | 0.031622777 | 0.9339 | 0.01364 |
| T47D | Ulixertinib | 0.1 | 0.8481 | 0.02263 |
| T47D | Ulixertinib | 0.1 | 0.9572 | -0.00551 |
| T47D | Ulixertinib | 0.1 | 0.8722 | 0.00367 |
| T47D | Ulixertinib | 0.316227766 | 0.6199 | 0.00798 |
| T47D | Ulixertinib | 0.316227766 | 0.6400 | -0.00345 |
| T47D | Ulixertinib | 0.316227766 | 0.8257 | 0.00370 |
| T47D | Ulixertinib | 1.0 | 0.8372 | -0.00054 |
| T47D | Ulixertinib | 1.0 | 0.7678 | 0.02902 |
| T47D | Ulixertinib | 1.0 | 0.7474 | 0.01924 |
| T47D | Ulixertinib | 3.16227766 | 0.5574 | 0.03703 |
| T47D | Ulixertinib | 3.16227766 | 0.6347 | -0.00038 |
| T47D | Ulixertinib | 3.16227766 | 0.6170 | 0.02846 |
| T47D | Ulixertinib | 10.0 | 0.2332 | 0.00805 |
| T47D | Ulixertinib | 10.0 | 0.2098 | 0.03127 |